Sanofi Genzyme Bioventures
Sanofi-Genzyme BioVentures (SGBV) is the corporate venture capital arm of Sanofi. Previously known as Genzyme Ventures, SGBV has an expanded mandate to invest across the broad business footprint of Sanofi. SGBV only invests in early stage companies with promising new products that may be future Sanofi pipeline candidates. Today, SGBV has assembled a portfolio of direct equity investments in a variety of promising innovative life-science companies.
SGBV is an important component of Sanofi’s broader global strategy to invigorate external innovation. In addition to engaging in venture capital, SGBV provides transaction support for equity investments made by other groups within Sanofi.